Konzerválószer-mentes krónikus kezelés glaucomában: A cseppkezelés okozta szemfelszínbetegség elkerülése

Translated title of the contribution: Chronic preservative-free treatment in glaucoma: Avoiding the eye drop induced ocular surface disease

Research output: Contribution to journalArticle

Abstract

Ocular surface disease is a frequently seen condition in the elderly in the general population. In glaucoma patients the glaucoma-therapy related ocular surface disease is a particularly serious and common condition with complex pathogenenesis. Preservatives, most commonly benzalkonium chloride, employed in intraocular pressure lowering eye drops frequently cause or worsen ocular surface disease in glaucoma. The symptoms frequently undermine both the adherence to the prescribed intraocular pressure lowering drops and the vision related quality of life. Therefore the success of long-term glaucoma care in glaucoma-therapy related ocular surface disease is reduced. The current article summarizes the main pathogenetic aspects of glaucoma-therapy related ocular surface disease, and presents how to eliminate the main causative factor and normalize the ocular surface by using completely preservative free topical medication in glaucoma.

Original languageHungarian
Pages (from-to)203-206
Number of pages4
JournalLege Artis Medicinae
Volume28
Issue number4-5
Publication statusPublished - Jan 1 2018

Fingerprint

Eye Diseases
Ophthalmic Solutions
Glaucoma
Intraocular Pressure
Therapeutics
Benzalkonium Compounds
Long-Term Care
Quality of Life
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Konzerválószer-mentes krónikus kezelés glaucomában : A cseppkezelés okozta szemfelszínbetegség elkerülése. / Holló, G.

In: Lege Artis Medicinae, Vol. 28, No. 4-5, 01.01.2018, p. 203-206.

Research output: Contribution to journalArticle

@article{0c01247a17ec417a808e894565e1c976,
title = "Konzerv{\'a}l{\'o}szer-mentes kr{\'o}nikus kezel{\'e}s glaucom{\'a}ban: A cseppkezel{\'e}s okozta szemfelsz{\'i}nbetegs{\'e}g elker{\"u}l{\'e}se",
abstract = "Ocular surface disease is a frequently seen condition in the elderly in the general population. In glaucoma patients the glaucoma-therapy related ocular surface disease is a particularly serious and common condition with complex pathogenenesis. Preservatives, most commonly benzalkonium chloride, employed in intraocular pressure lowering eye drops frequently cause or worsen ocular surface disease in glaucoma. The symptoms frequently undermine both the adherence to the prescribed intraocular pressure lowering drops and the vision related quality of life. Therefore the success of long-term glaucoma care in glaucoma-therapy related ocular surface disease is reduced. The current article summarizes the main pathogenetic aspects of glaucoma-therapy related ocular surface disease, and presents how to eliminate the main causative factor and normalize the ocular surface by using completely preservative free topical medication in glaucoma.",
keywords = "Glaucoma, Ocular surface disease, Preservative-free topical medication, Preservatives",
author = "G. Holl{\'o}",
year = "2018",
month = "1",
day = "1",
language = "Hungarian",
volume = "28",
pages = "203--206",
journal = "Lege Artis Medicinae",
issn = "0866-4811",
publisher = "Literatura Medica Publishing House",
number = "4-5",

}

TY - JOUR

T1 - Konzerválószer-mentes krónikus kezelés glaucomában

T2 - A cseppkezelés okozta szemfelszínbetegség elkerülése

AU - Holló, G.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Ocular surface disease is a frequently seen condition in the elderly in the general population. In glaucoma patients the glaucoma-therapy related ocular surface disease is a particularly serious and common condition with complex pathogenenesis. Preservatives, most commonly benzalkonium chloride, employed in intraocular pressure lowering eye drops frequently cause or worsen ocular surface disease in glaucoma. The symptoms frequently undermine both the adherence to the prescribed intraocular pressure lowering drops and the vision related quality of life. Therefore the success of long-term glaucoma care in glaucoma-therapy related ocular surface disease is reduced. The current article summarizes the main pathogenetic aspects of glaucoma-therapy related ocular surface disease, and presents how to eliminate the main causative factor and normalize the ocular surface by using completely preservative free topical medication in glaucoma.

AB - Ocular surface disease is a frequently seen condition in the elderly in the general population. In glaucoma patients the glaucoma-therapy related ocular surface disease is a particularly serious and common condition with complex pathogenenesis. Preservatives, most commonly benzalkonium chloride, employed in intraocular pressure lowering eye drops frequently cause or worsen ocular surface disease in glaucoma. The symptoms frequently undermine both the adherence to the prescribed intraocular pressure lowering drops and the vision related quality of life. Therefore the success of long-term glaucoma care in glaucoma-therapy related ocular surface disease is reduced. The current article summarizes the main pathogenetic aspects of glaucoma-therapy related ocular surface disease, and presents how to eliminate the main causative factor and normalize the ocular surface by using completely preservative free topical medication in glaucoma.

KW - Glaucoma

KW - Ocular surface disease

KW - Preservative-free topical medication

KW - Preservatives

UR - http://www.scopus.com/inward/record.url?scp=85050390807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050390807&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85050390807

VL - 28

SP - 203

EP - 206

JO - Lege Artis Medicinae

JF - Lege Artis Medicinae

SN - 0866-4811

IS - 4-5

ER -